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Inherited germline polymorphisms can cause gene
expression levels in normal tissues to differ substan-
tially between individuals. We present an analysis of
the genetic architecture of normal adult skin from
470 genetically uniquemice, demonstrating the effect
of germline variants, skin tissue location, and pertur-
bation by exogenous inflammation or tumorigenesis
on gene signaling pathways. Gene networks related
to specific cell types and signaling pathways,
including sonic hedgehog (Shh), Wnt, Lgr family
stem cell markers, and keratins, differed at these tis-
sue sites, suggesting mechanisms for the differential
susceptibility of dorsal and tail skin to development
of skin diseases and tumorigenesis. The Pten tumor
suppressor gene network is rewired in premalignant
tumors compared to normal tissue, but this response
to perturbation is lost during malignant progression.
We present a software package for expression quan-
titative trait loci (eQTL) network analysis and demon-
strate hownetwork analysis ofwhole tissuesprovides
insights into interactions between cell compartments
and signaling molecules.
INTRODUCTION
The skin is the largest human organ, forming an essential barrier
against environmental insults, including physical and chemical
exposures. Skin is the tissue of origin of the commonest form
of cancer in white populations (Diepgen and Mahler, 2002) as
well as a host of other diseases ranging from relatively common
inflammatory conditions, such as atopic dermatitis, to rare
life-threatening conditions, such as the skin fragility syndromeCe
This is an open access article under the CC BY-Nepidermolysis bullosa. Studies both in mice and in humans
have uncovered the underlying genetic basis of many skin dis-
eases and have led to pioneering discoveries in tissue transplan-
tation, regeneration, and stem cell biology (Blanpain and Fuchs,
2006). Keratinocytes, the most common cell type in skin, pro-
duce several closely related families of proteins with distinctive
locations and functions (Fuchs, 1995; Schneider et al., 2009).
Keratins were initially characterized as structural proteins that
form the cytoskeletal architecture (Steinert et al., 1985), but
they can also function in signaling pathways in skin in response
to tissue perturbation (Arwert et al., 2012; Gu and Coulombe,
2007; Paramio and Jorcano, 2002).
Skin morphology, function, and tumor susceptibility vary in
different parts of the body (Rinn et al., 2008). To withstand phys-
ical stress, the soles of human feet, mouse paws, and mouse
tails have thicker and tougher epidermal layers than dorsal
skin. Mouse dorsal skin, but not tail skin, is highly sensitized to
squamous papilloma development induced by chemical initia-
tors and promoters of carcinogenesis (Schweizer and Marks,
1977b). Exposing Ptch1+/ mice to ionizing radiation produces
basal cell carcinomas (BCCs) in dorsal skin (Wang et al., 2011).
In contrast, activation of the hedgehog pathway by oncogenic
smoothened (Smo) driven by widely expressedKrt14-Cre results
in development of BCCs preferentially inmouse tail skin (Youssef
et al., 2012). Similarly, overexpression of Gli2 using a Krt5
promoter also led to development of BCCs in the tail skin
(Grachtchouk et al., 2000). The underlying basis of these site-
specific phenotypes is not presently understood.
In this study, we identify significant differences in the network
architecture of signaling pathways between mouse dorsal and
tail skin using gene expression quantitative trait loci (eQTL) and
differential correlation analysis. We performed this analysis in a
cohort of 470 genetically distinct animals produced by crossing
FVB/N and Mus spretus mice, two highly divergent strains. We
analyzed differential gene expression networks after stimulation
of inflammation and epithelial proliferation using the tumorll Reports 16, 1153–1165, July 26, 2016 ª 2016 The Authors. 1153
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 1. Synchronized Expression ofMajor
Signaling Pathways in Dorsal Skin
(A and B) H&E stain of (A) tail skin and (B) dorsal
skin from an 8-week-old mouse. Scale bars indi-
cate 500 mM.
(C) Outline of the FVBBS breeding scheme and
tissues obtained.
(D) Gene expression levels of key genes in tail,
dorsal anagen, and dorsal telogen skin.
(E) Scatterplot comparing the difference in eQTL
effect size for each probeset in tail and dorsal
samples (y axis) with the difference in mean
expression levels in tail and dorsal samples
(x axis). Probes with significant eQTL in either tail
or dorsal skin drawn are in black but otherwise
drawn in blue. The genes with the largest increase
in eQTL strength tended to have the smallest
change in gene expression levels.
(F) Statistical strength of the eQTL for Rps26 in tail
skin (solid line) and dorsal skin (dashed line) on
chromosome 10.
(G and H) Expression of Rps26 in tail skin (G) and
dorsal skin (H) separated by genotype at chro-
mosome 10 (118 Mb). F/F, homozygous FVB/N;
F/S, heterozygous FVB/N/Spret/Ei.promoter TPA (tetradecanoyl-phorbol acetate) or in tumors
induced by sequential treatment with dimethylbenzanthracene
(DMBA) and TPA. We also present CARMEN, a user-friendly
software package for network analysis. We demonstrate how
this systems genetics strategy identifies the genes and path-
ways that are engaged in response to different forms of perturba-
tion. These resources provide opportunities for generation and
testing of many specific hypotheses related to skin biology.
RESULTS
Gene Expression Networks Reconstruct the Cellular
Composition of the Skin
Adult mouse dorsal skin in the resting (telogen) phase has thin
cornified and epithelial layers and small, densely packed hair fol-1154 Cell Reports 16, 1153–1165, July 26, 2016licles, whilemouse tail skin has a thick and
scaled cornified envelope layer and large,
sparsely placed anagen hair follicles
(Schweizer and Marks, 1977a) (Figures
1A and 1B). To investigate the genetic
basis of the skin site-specific biological
differences, we measured gene expres-
sion in 222 dorsal skins and 248 tail skins
from a backcross of 8-week-old Mus
musculus (FVB/N) and Mus spretus
mice, referred to as FVBBX mice (Fig-
ure 1C; Experimental Procedures). Tail
skins had significantly higher expression
of genes expressed in the outer cornified
layer of the skin such as small proline re-
ceptor 2b (Sprr2b; Figure 1D). Individual
hair follicles cycle through periods of
growth (anagen) and destruction (cata-gen), with an intervening period of quiescence (telogen) (Stenn
and Paus, 2001). Hair follicle cycling affects the skin’s physical
structure and its susceptibility to experimentalmodels of carcino-
genesis (Mancuso et al., 2006; Miller et al., 1993). In the first
2 months after a mouse is born, its dorsal hair follicles progress
synchronously through this cycle in a temporally predictable
manner (M€uller-Ro¨ver et al., 2001). Expression of hair-follicle
inner-root-sheath-specific keratins such as Krt26 was at or
below background levels in 77% of the dorsal skin samples (Fig-
ure 1D), indicating that follicles in these skins were in telogen. All
tail samples expressed hair-follicle-specific keratins at levels
above background, consistent with follicles in tail being primarily
in the anagen phase (Figures 1A and 1D).
Expression of mitotic markers such as Aurora kinase A (Aurka)
was significantly higher in tail than in dorsal telogen or anagen
skin (Figure 1D), consistent with elevated proliferation rates. In
agreement with prior observations of site-specific immune re-
sponses in the skin (Bergstresser et al., 1980; Nabors and Farrell,
1994; Tong et al., 2014), tail skin showed dramatically reduced
expression of markers of tissue-resident Langerhans cells such
as Il34 (Wang et al., 2012), genes of the Major Histocompatibility
Complex (MHC) such asH2-m2, and T cell surfacemarkers such
as Cd3e (Figure 1D). The highest expression of these genes in
dorsal was during telogen phase (Figure 1D), confirming mea-
surements made by Paus and colleagues (Paus et al., 1998).
The Genetic Influence on Energy and Metabolism Gene
Expression Is Stronger in Tail Skin
We hypothesized that the genetic architectures of tail and dorsal
skin would differ in ways that reflect their distinct forms and func-
tions. To test this idea, we performed an eQTL study in the 89
FVBBX mice where we had both dorsal skin and tail skin from
the same animal. Gene expression data were corrected for
strain-specific SNP effects on microarray hybridization (Experi-
mental Procedures). Using matched tissues reduced non-ge-
netic variation and provided equivalent statistical power in both
conditions. Surprisingly, we identified 4,753 genes with signifi-
cant eQTL in tail skin but only 1,710 genes with significant
eQTL in dorsal skin.
One possible explanation for this result would be if cell popu-
lations present preferentially in tail skin were the source of addi-
tional significant eQTL in tails. However, the number of genes ex-
pressed above background levels was similar in tail and dorsal
skin, and only a small number of genes had nearly complete tis-
sue-specific expression. Although most genes were significantly
differentially expressed between matched tail and dorsal skin,
the effect size was usually very small (median fold change 6%
higher in tail; Figure 1E). Geneswith large location-specific differ-
ences in expression did not tend to have large differences in
eQTL strength. Intermediate filament keratins in the hair follicle
network such as Krt26 had the highest relative mean expression
levels in tail skin (Figure 1E), reflecting the fact that most
matched dorsal skin samples were in telogen. Many of the genes
with highest relative expression in dorsal skin were T cell surface
markers such as Cd3e (Figure 1D). However, the eQTL strength
of these hair follicle keratins and T cell markers was similar in
both tail and dorsal skin (Figure 1E). There was not a significant
correlation between the difference in gene expression levels and
the difference in eQTL strength. The peaks of almost all eQTL
mapped to the same locus in tail and dorsal skin samples, and
after increasing the number of samples in the tail eQTL analysis
from 89 to 248 by adding additional unmatched FVBBX animals,
we did not identify more than a handful of genes with eQTL
exclusively in dorsal skin. These results suggest the tissue
locations differed in linkage strength but not in their genetic
architecture.
Gene Ontology enrichment analysis indicated that genes with
the largest increase in eQTL strength (log10P increase R 10)
were significantly enriched for roles in the mitochondria, cellular
metabolism, translation, and energy production. These genes
usually had very small differences in expression levels. One
example was Rps26, a ribosomal protein mutated in Diamond-
Blackfan anemia, which can affect TP53 transactivation (Cuiet al., 2014; Doherty et al., 2010).Rps26was expressed at nearly
identical levels in tail and dorsal skin but was under much stron-
ger genetic control in tail skin (logarithm of the odds [LOD]tail 21.8
versus LODdorsal 6.4; Figures 1F–1H). We interpret this to mean
that the increase in tail eQTL strength was not simply the result
of cell populations present in the tail skin and absent in dorsal
skin, or the result of higher expression levels producing stronger
linkage signals. Rather, these differences reflect differences in
the activity of genes linked to protein production and cellular
metabolism. This was concordant with the observation that
levels of mitotic genes such as Aurora kinase A are expressed
at constitutively higher levels in tail skin (Figure 1D).
Conserved and Tissue-Specific Networks in Dorsal and
Tail Skins
Signals from the Wnt and hedgehog pathways organize the hair
placode during mouse embryonic development, andWnt activa-
tion from the dermal papillae is required for follicle down-growth
and cycling (Chiang et al., 1999; Gat et al., 1998; Huelsken et al.,
2001; Kishimoto et al., 2000; St-Jacques et al., 1998). Expres-
sion of the Wnt-associated transcription factor Lef1 (DasGupta
and Fuchs, 1999) was modestly higher in tail skin and dorsal an-
agen skin than in dorsal telogen, but expression levels of the
hedgehog pathway genes Smo and Gli1 were nearly identical
between these tissues (Figure 1D). Gene expression correlation
analysis can reveal features of signaling networks that are not
detectable by measuring differential expression levels between
tissues. Correlation was among the first statistical tools to be
applied to microarray data to identify sets of genes that act in
concert (Chu et al., 1998). In contrast, relatively few studies
have exploited how the differences in correlation between con-
trasting conditions can elucidate the changes in how genes
work together under different biological conditions. Several
groups have developed formal methods to analyze differential
correlation (reviewed in de la Fuente, 2010). Some methods
determine whether pre-specified gene sets are differently corre-
lated in two conditions (Braun et al., 2008; Choi and Kendziorski,
2009), while others discover gene sets directly from the data
(Watson, 2006). We used CARMEN to calculate differential cor-
relation between tail and dorsal telogen tissues (Experimental
Procedures). We then calculated pairwise differential correlation
genome-wide and ranked each gene by the number of signifi-
cant differential correlations between the two tissue conditions.
The 100 genes with the largest number of rewired correlations
was enriched for genes with key roles in Wnt signaling such as
Lef1, Fzd1, Tnik,Rspo3, and Lgr5, as well as geneswith key roles
in hair follicle stem cell biology such as Lgr5, Msx2, Lhx2,
Hoxb13, and Dlx3 (Table S1). The second-most-frequently re-
wired gene, TRAF2 and NCK interacting kinase (Tnik), activates
Wnt target genes in intestinal crypts (Mahmoudi et al., 2009)
and has a role inWnt-driven colorectal tumorigenesis (Shitashige
et al., 2010). In tail skin, but not dorsal telogen skin, expression of
Tnikwas significantly correlated with expression of Lef1 andGli1
(Figure 2A), whereas in dorsal, but not tail, skin Tnik expression
was correlated with expression of adherens junctions genes
such as e-cadherin (Cdh1) and T cell lymphoma invasion and
metastasis 1 (Tiam1) (Figure 2B). Plotting these gene networks
(Figures 2C and 2D) allows the identification of gene pathwayCell Reports 16, 1153–1165, July 26, 2016 1155
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Figure 2. Keratin Correlation Networks in
Tail and Dorsal Skin
(A and B) Gene expression levels of (A) Tnik, Lef1,
and Gli1 and (B) Tnik, Cdh1, and Tiam1 in mouse
dorsal telogen and tail skin, sorted by increasing
Tnik expression.
(C and D) Gene expression correlation of genes
differentially expressed with Tnik expression in tail
skin (C) and telogen dorsal skin (D).
(E and F) Gene expression correlation networks for
all keratins in tail skin (E) and dorsal skin (F); Krt1,
Krt2, and Krt10 are underlined where present.
Edges connect genes (boxes) with significantly
expressed genes; black edges are inverse corre-
lation, and blue edges are direct correlation.
(G) Gene expression correlation network for Krt79.
(H and I) Immunofluorescence image for anti-
bodies against (H) Lrig1 (red) and Krt79 (green) in
FVB mice and (I) Efnb2.rewiring that would not be detectable from analysis of gene
expression levels alone.
Keratin Gene Expression Networks in Dorsal and
Tail Skin
Many skin disorders are caused by germline alterations in genes
encoding keratins, resulting in hyperproliferation, epidermal bar-
rier defects, or defective control of epidermal permeability (Lane
and McLean, 2004). We hypothesized that network expression
analysis could identify rewired gene expression pathways asso-
ciated with differing susceptibility to disease models. Mutations
in Krt1 and Krt10 are linked to epidermolytic hyperkeratosis and
ichthyosis, rare conditions thT result in blistering and thickening
of skin (Cheng et al., 1992; Rothnagel et al., 1992). The palmo-
plantar variety of hyperkeratosis particularly affects the palms1156 Cell Reports 16, 1153–1165, July 26, 2016and soles of the feet. The Dsk2 mutation
at Krt2, a model for epidermolysis bul-
losa, results in hyperkeratosis in mouse
footpads, ears, and tails, but not dorsal
skin (Fitch et al., 2003; Rentrop et al.,
1987). Correlation analysis of keratin
gene expression in dorsal and tail skin
(Figures 2E and 2F; Krt1, Krt2, and
Krt10 underlined) provided a rationale
for the functional significance of tail-spe-
cific expression of Krt2 (Rentrop et al.,
1987). Expression of type II keratin Krt1
and type I keratin Krt10, while strongly
correlated in dorsal skin, showed no
mRNA relationship in tail skin. Although
both Krt10 and Krt1 were highly ex-
pressed at the mRNA level in tails, Krt10
was significantly correlated only with
Krt2. In agreement with these data, germ-
line deletion of Krt2 in the mouse causes
acanthosis, hyperkeratosis, and inflam-
mation of the ear and tail, with accumula-
tion of aggregates of Krt10 (Fischer et al.,2014). Correlation network analysis would correctly have pre-
dicted that in thickened skin locations such as the tail, Krt2
substitutes for roles normally played by Krt1 in barrier function
and inflammation.
We further analyzed the mRNA expression network for a kera-
tin that is localized within a specific compartment of the skin. We
calculated a correlation network for expression of the type II ker-
atin Krt79 (Figure 2G), which is expressed in cells that line the
infundibulum and co-localizes in part with expression of Krt17
(Veniaminova et al., 2013). The expression network for Krt79
included, in addition to Krt17, the stem cell marker leucine-rich
repeats and immunoglobulin-like domains 1 (Lrig1). Importantly,
Lrig1 is a transmembrane protein and amarker of a stem cell that
maintains the infundibulum and sebaceous gland, but not the
hair follicle or the interfollicular epidermis (Page et al., 2013;
Veniaminova et al., 2013). Immunohistochemical analysis
confirmed that Krt79 and Lrig1 protein are both localized within
the infundibulum region, but primarily in adjacent cells rather
than in exactly the same cell population (Figure 2H).
Expression of Efnb2 was also significantly correlated with
expression of Krt79 in this network. Since very little is known
about possible functions and localization of Efnb2 in skin, we
carried out an immunohistochemical analysis of Efnb2 expres-
sion and found that it is also expressed in the infundibulum
and sebaceous gland, in a pattern that overlaps with but is
more extensive than Krt79 and Lrig1 (Figure 2I). We conclude
that analysis of expression networks derived from this heteroge-
neous mouse population can provide novel information on the
localization and possible functional relationships between genes
expressed in complex whole tissues in vivo. It is, however,
important to note that many of the statistically significant genes
within the Krt79 network may be expressed outside the infundib-
ulum. While it is possible that significantly correlated genes are
expressed in the same cells within a tissue compartment or
interact within the same signaling pathway, it is also possible
that RNA correlations reflect paracrine relationships between
adjacent cell types or a hierarchical relationship within a cell
lineage.
Network Changes in Response to Inflammatory Agents
It is also possible to visualize network correlations using
samples from inbred mice subjected to a strong perturbation
such as induction of inflammation. To model epithelial response
to inflammation, we treated dorsal skin of inbred FVB mice with
the phorbol ester TPA, which results in edema and an influx of in-
flammatory cells into the skin (F€urstenberger and Marks, 1983;
Schlingemann et al., 2003). TPA treatment has been observed
to induce differentiation of basal keratinocytes (Reiners and
Slaga, 1983). On induction of a wound stimulus, cells positive
for the Wnt-responsive stem cell markers Lgr5 and Lgr6 can
give rise to progeny that migrate into the epidermis and may
contribute to the wound-healing process (Kasper et al., 2011).
Correlation network analysis of gene expression across a
1-week time course after a single treatment with TPA (Figure 3A)
revealed the coordinated response of cytokines, keratins, and
stem cell markers over time. Code to reproduce the analysis
and figures in this manuscript is publicly available at http://
davidquigley.com/publications.html.
Expression of the immediate response interleukins Il1b and Il6
increased 8- to 16-fold 2 hr after TPA treatment (Figure 3B). The
‘‘acute inflammatory response’’ motif in Figure 3A includes Il1b
as well as other known early response genes such as Tgfa,
Junb, and Nfkb2. Expression of macrophage surface markers
such as macrophage scavenger receptor 1 (Msr1) peaked at a
5-fold increase after 12 hr, consistent with the influx of macro-
phages into the treated skin. Within the ‘‘Mitosis’’ network,
expression of markers of the M phase of the cell cycle such as
Mki67 decreased immediately after treatment only to rebound
to higher-than-baseline levels by 24 hr, in agreement with earlier
observations of early decrease in DNA synthesis after TPA treat-
ment, followed by entry into S phase after 12–18 hr (Balmain
et al., 1977). Expression of the proliferation-associated keratins
Krt6a, Krt6b, Krt16, and Krt17 increased significantly after TPAtreatment, and these genes were linked to the ‘‘Skin Barrier
and Cornified Envelope’’ module. Expression of the Wnt
signaling agonist Rspo3 and Wnt effector Lef1 was significantly
decreased by TPA treatment, with Rspo3 expression gradually
recovering after acute inflammatory stimulus (Glinka et al., 2011).
We summarize the kinetics of epithelial response to TPA expo-
sure using markers of stem, basal, suprabasal, and terminally
differentiated cells in Figure 3C. Bulge stem cell markers (Lgr5)
drop immediately by 4-fold and slowly recover to baseline levels
by 72 hr. Early differentiation markers (involucrin) increased to a
peak at 2 hr, followed by markers of the primitive epithelium
(Krt8), which increase to peak at 6 hr and revert to homeostatic
levels by 12 hr. The suprabasal epithelium (Krt1) shows the in-
verse trend, decreasing at 6 hr and recovering by 24 hr. Markers
of the cornified envelope (Sprr1b) and keratin wound response
(Krt6a) increase to a peak at 12 hr and are still significantly
elevated 48 hr after treatment. These observations are compat-
ible with an immediate differentiation response to TPA by primi-
tive cells and suprabasal cells, followed by an increase in basal
cell production to replenish the suprabasal cell population be-
tween 12 and 24 hr after treatment. The early drop in mitotic
gene expression suggested the increase in involucrin and Sprr1b
expression was the result of a direct induction of a differentiation
response rather than a consequence of proliferation. Our obser-
vations are compatible with earlier morphological and biochem-
ical observations of the effects of TPA on mouse skin, which
showed an early induction of differentiation markers and a
change in the balance of basal and suprabasal cells following
TPA treatment (Reiners and Slaga, 1983).
Keratin Gene Networks Linked to Pachyonychia
Congenita
Germline mutations in Krt6a, Krt6b, Krt16, and Krt17 are all
linked to the rare skin disease pachyonychia congenita (PC), a
congenital disorder characterized by blisters, thickened nails,
and hyperkeratosis (Bowden et al., 1995; McLean et al., 1995).
Network analysis revealed strong correlations between these
mRNA levels of these genes under normal and inflammatory
conditions, suggesting coordinated functions in skin architec-
ture. The type II keratins Krt6a and Krt6b are thought to hetero-
dimerize with the type I keratin Krt16, but in normal dorsal skin,
expression of Krt16 was significantly correlated with expression
of Krt6a, but not Krt6b (Figure 2F), suggesting preferential heter-
odimerization between Krt16 and Krt6a compared to Krt6b,
while in normal tail skin, expression of Krt16 was linked to
expression of both Krt6a and Krt6b (Figure 2E). To our knowl-
edge, there are currently no antibodies that can reliably distin-
guish Krt6a from Krt6b to address the question of differential
binding under these conditions. After TPA treatment, the Krt16
expression profile was significantly correlated with that of
Krt6b, as well as Krt6a and barrier/inflammation genes such as
S100a8, Lce3a, and small proline receptors Sprr2e and Sprr2d
(Table S2). There was also significant differential correlation be-
tween expression of Krt16 and S100a8, Defb3, and other genes
induced by TPA exposure when comparing untreated FVBBX tail
skin to dorsal skin (Table S3). The tail-specific correlation of
Krt16 with other genes induced during wound response, as
well as elevated constitutive expression of Krt16 in normal tail,Cell Reports 16, 1153–1165, July 26, 2016 1157
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was compatible with elevated keratinocyte proliferation in tail
skin and was reminiscent of the wound response seen in TPA-
treated dorsal skin. These observations are consistent with pre-
vious analysis of data from the tail skins of aged (>1 year old) tu-
mor-bearing mice, which implicated Krt16 in regulation of innate
immune responses to barrier dysfunction (Lessard et al., 2013).
Network analysis of Krt17 in normal tail skin, in contrast to the
analysis ofKrt16, showed no significant correlations withS100a8
or other markers of acute inflammatory responses but was linked
to expression of hair follicle keratins (Tables S4 and S5; Figures
2E and 2F). In dorsal skin, Krt17 was correlated with a number
of epidermal stem cell markers (e.g., Sox9, Dlx3, and Tbx1) as
well as Krt6a but only weakly with Krt16. However, all of the
genes that play causative roles in PC (Krt6a, Krt6b, Krt16, and
Krt17) were significantly correlated with each other after treat-
ment of skin with TPA, indicating that these genes form part of
a coordinated network response to inflammation and tissue
regeneration.
SmoothenedActivity Is RewiredbetweenTail andDorsal
Skin
Skin tumorigenesis studies have shown differences in suscepti-
bility of tail and dorsal skin to induction of BCCs by activation of
the Shh signaling pathway. We hypothesized that tissue-specific
regulation of Smoothened is responsible for the observation that
models of BCC that activate Smoothened only produce tumors
on the tail skin. It has previously been reported that Smo protein
is absent in tail follicles (Wang et al., 2011). We first performed
immunostaining for Smo protein with the antibody used by
Wang and colleagues (Wang et al., 2011). In agreement with their
results, we detected cytoplasmic Smo protein at the inner root
sheath of dorsal anagen follicles (Figures 4A and 4B). In contrast
to the previous report, we also detected Smo protein at the base
of tail follicles (Figures 4C and 4D). Specificity of Smo staining
was confirmed by staining Smo induced by the Ptch+/ radiation
model (Figure S1). We then co-stained for Smo protein and
EGFP in mice expressing EGFP at the endogenous Lgr5 locus.
Dorsal telogen skin showed Lgr5-positive cells at the dermal
papilla, but no Smo protein, as expected (Figure 4E). Tail skin
showed co-localization of Lgr5 and Smo protein in cells between
the dermal papilla and bulge region (Figure 4F), thus confirming
that Smo is in fact expressed in tail skin during anagen.
Our data show that Smo protein is expressed in both dorsal
and tail skin and furthermore that the average level of Smooth-
ened mRNA expression is nearly identical in skin from both sites
(Figure 1D). However, we found 676 genes with significant differ-
ential correlation with Smoothened in these tissues (p < 0.05,
Bonferroni correction, see Experimental Procedures). Gene
Ontology enrichment analysis indicated significant activation of
correlation in tails between expression of Smoothened and
both canonical Wnt receptor signaling (p < 6 3 105) and theFigure 3. Keratin Correlation and TPA Response Networks
(A) Gene expression correlation network for genes with significantly correlated re
(B) Box plots of gene expression in dorsal skin at baseline (0 hr) and at time points
was 9 (0 hr), 6 (2 hr), 4 (4 hr), 7 (6 hr), 6 (12 hr), 7 (24 hr), 8 (48 hr), 4 (72 hr), and 4
(C) Mean expression levels of Krt1, Involucrin, Sprr1b, Krt6a, Lgr5, and Krt8 in the
since treatment.hair follicle cycle (p < 2 3 105). We plotted correlation between
key genes in these networks, illustrating that while there was a
constitutive association between expression levels of Lef1 and
hedgehog genes Gli1 and Ptch1 in both compartments, the
association between Smo and the Wnt and hair follicle gene
networks was restricted to tail skin (Figures 4G and 4H). We
conclude that constitutive expression of a tail network encom-
passing Smo and components of the Wnt-Lef1 signaling
pathway may explain the development of BCCs preferentially
in the tail in spite of widespread targeting of mutant Smo to mul-
tiple body sites, including dorsal skin, using the Krt14 promoter
(Wong and Reiter, 2011; Youssef et al., 2010).
Rewiring of Tumor Suppressor Gene Networks during
Premalignancy
We then applied differential correlation analysis to identify how
relationships between genes are altered during tumorigenesis,
analyzing previously published gene expression measurements
on normal skin, benign tumors, and malignant tumors (Quigley
et al., 2009; Quigley et al., 2011). Skin tumors were induced on
mice using a two-stage skin carcinogenesis protocol as previ-
ously described; briefly, tumors were initiated using DMBA,
which induces oncogenic mutations in Hras1 (Quintanilla et al.,
1986), and were then promoted with TPA, resulting in benign
papillomas, some of which progress to malignant invasive
carcinomas.
The most frequently differentially correlated genes when
comparing normal skin to benign tumorswere the ribosomal pro-
teinRps7 and phosphatase and tensin homolog deleted on chro-
mosome 10 (Pten). Both genes were robustly expressed in skin,
papillomas, and carcinomas, with mean change in expression
levels between matched normal skin and papillomas of <20%.
Analysis based on differential expression would not suggest
that these genes are of special interest during tumorigenesis.
However, these genes are both linked to tumor suppressor
pathways potentially activated in epithelial tumors. Rps7 binds
directly to Mdm2, inhibiting its ability to degrade p53 (Zhu
et al., 2009). Pten is an antagonist of the PI3-kinase signaling
pathway, which is frequently inactivated in epithelial tumors (Sal-
mena et al., 2008). Mice with heterozygous knockouts of Pten
develop spontaneous tumors; mice with heterozygous or homo-
zygous knockout of Pten targeted to their keratinocytes show a
dose-dependent increase in spontaneous skin tumor formation
and susceptibility to DMBA/TPA treatment (Suzuki et al., 2003).
We have previously shown that 70% of the carcinomas that arise
in Pten+/ mice after DMBA/TPA treatment do not have an Hras
mutation, but all of these tumors lost their wild-type Pten allele.
Wild-type animals treated with DMBA/TPA did not lose Pten
copies or develop somatic Ptenmutations in papilloma genomic
DNA (Mao et al., 2004). These previous data identified a specific,
mutually exclusive relationship between Hras mutations andsponse in dorsal skin to TPA exposure.
from 2 hr to 1 week after TPA treatment. Number of animals for each time point
(1 week).
TPA treatment experiment, with the x axis plotted to scale for number of hours
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Figure 4. Rewired Hedgehog Networks in
Tail and Dorsal Hair Follicles
Correlation networks for key hedgehog, Wnt, and
hair follicle genes in (C) dorsal and (D) tail skin.
Lines connect significantly correlated gene pairs.
(A–D) Mouse skin immunostained with an anti-
SMO antibody (red) and counter-stained with
DAPI (blue). SMO protein was present in (A) dorsal
anagen follicles (B shows higher magnification of
the dashed box) and (C) tail follicles (D, higher
magnification) most prominently near the dermal
papillae. Lower- and higher-magnification scale
bars indicate 500 and 200 mM, respectively.
(E and F) LGR5-EGFP dorsal telogen mouse skin
(E) and tail skin (F) immunostained with an anti-
SMO antibody (red) and anti-EGFP antibody
(green) and counterstained with DAPI (blue). Scale
bar is 50 mM, and images were taken at 403.
(G and H) Correlation networks for key hedgehog,
Wnt, and hair follicle genes in dorsal skin (G) and
tail skin (H), illustrating the tail-skin-specific cor-
relation between expression of Smo and expres-
sion of the Wnt and hair follicle networks. Lines
connect significantly correlated gene pairs.Pten signaling in mouse skin. This relationship is supported by
the observation that across the whole genome, Pten was the
third most frequently ‘‘rewired’’ genes in papillomas carrying
Hras mutations. Several of the genes that acquire correlations
with Pten in papillomas are involved in alternative tumor sup-
pressor pathways (Table S6), suggesting that this rewiring is
part of a concerted response to perturbation induced by activa-
tion of Ras signaling.
In many cases, the significant correlations with Pten that
were acquired in premalignant papillomas were subsequently
lost during malignant progression to carcinomas. This was the
case with Pten and the transforming growth factor beta (TGF-b)
signaling mediator SMAD family member 4 (Smad4), which is a
well-characterized tumor suppressor gene both in mouse and
human tumors (Figures 5A–5C). Keratinocyte-specific inactiva-
tion of Smad4 blocks hair follicle differentiation and cycling and
leads to invasive squamous cell carcinomas, while deletion of
both Smad4 and Pten results in accelerated tumorigenesis
(Yang et al., 2005). Moreover, Smad4 and Pten synergize to pre-1160 Cell Reports 16, 1153–1165, July 26, 2016vent pancreatic ductal adenocarcinoma
(Ding et al., 2011; Xu et al., 2010).
Pten and Smad4 proteins are ex-
pressed in the epithelial layer of normal
dorsal skin with diffuse cytoplasmic
staining (Figures 5D and 5F). In contrast,
in papillomas, Pten protein is expressed
at moderately elevated levels in the
membranes of epithelial cells, a location
compatible with its known activity on
the cell membrane (Figure 5E), while
Smad4 protein is expressed at moder-
ately higher levels in the nucleus. Our re-
sults suggest that even in the absence of
inactivating mutations in Pten (McCreeryet al., 2015), genetic networks are rewired to activate tumor sup-
pressor pathways in benign tumors as a response to activated
Ras signaling. Carcinomas, however, no longer show this acti-
vated response pattern, suggesting that alternative genetic or
epigenetic mechanisms lead to loss of these growth controlling
pathways during tumor progression.
DISCUSSION
Human skin is a self-renewing tissue that has evolved specific
functions according to location in the body. These functions
may require the presence of specific cell types in particular loca-
tions or gene expression patterns that determine responses to
local perturbations or exogenous insults (Rinn et al., 2008).
In the mouse, a similar heterogeneity in function is determined
by site-specific requirements such as physical stress, barrier
function, or immune responses. Previous studies have shown
that susceptibility to development of skin tumors is dependent
on location. Transgenic approaches in which keratin gene
Figure 5. Tumor Suppressor Gene Rewiring during Tumorigenesis
(A–C) Expression of Pten and Smad4 in normal skin, benign tumors, and malignant carcinomas showing significant correlation in benign tumors, but not normal
skin or malignant carcinomas.
(D–G) Immunohistochemistry of adjacent normal skin (D and F) and benign tumors (E and G) shown at 403 (insets at 103).promoters were used to drive expression of oncogenes in skin
demonstrated preferential induction of tumors at specific sites,
in spite of widespread expression of the gene promoters used.
For example, expression of mutant Hras under the control of a
keratin 5 promoter led to squamous tumors of the back and
sometimes ventral skin (Wakabayashi et al., 2007), whereas acti-
vation of mutant Smo in cells expressing keratin 14 gave rise to
BCCs mainly in tail or ear skin (Wong and Reiter, 2011; Youssefet al., 2012). Chemical carcinogenesis studies also showed that
dorsal skin, but not tail skin, is susceptible to squamous tumor
development (Schweizer and Marks, 1977b).
In the present study we have explored the basis for these site-
specific functional differences using gene expression network
analysis of dorsal and tail skins from a genetically heterogeneous
mouse population. Randomized inheritance of polymorphic var-
iants between the strongly divergent Mus musculus and MusCell Reports 16, 1153–1165, July 26, 2016 1161
Figure 6. Summary of Network Analysis and Perturbations Pre-
sented in This Study
CARMEN can be used to analyze the network architecture of tissue in
homeostasis and how that architecture changes in response to stimulation.
Gene co-expression networks can be determined from tissue affected by
systemic perturbations, including genetic variation, exogenous stimulation,
tissue-specific differences, and disease progression.spretus (Dejager et al., 2009) produced high variance in gene
expression between normal individuals. Measuring the co-
variation of these genes allowed us to visualize the network ar-
chitecture of normal skin in two physically and functionally
distinct locations.
Analysis of genetic control of gene expression in age- and
gender-matched mice showed that the statistical strength of
eQTL calculated in 89 tail skins was much higher than that of
eQTL calculated from the same number of dorsal skins. Surpris-
ingly, the stronger eQTL were not enriched for roles in either hair
follicle control or in cell populations such as Langerhans cells
that differ in frequency between tail and dorsal. We found genes
with stronger eQTL in tail had roles in ribosomal structure, trans-
lation, and energy metabolism. We hypothesize that the appar-
ently constitutive anagen at 8 weeks of age in tail skin plays an
important part in explaining this result and is a key difference
between tail and dorsal skin overall. While most dorsal tissue
samples at this time point were in telogen, each tail sample con-
tained at least some anagen activity. The constitutive anagen
and increased proliferative activity of tail skin may allow for
clearer dissection of genetic differences between the parental
strains.
Differential Cancer Susceptibility in Dorsal and Tail Skin
There is considerable debate over the cellular origins of skin
BCCs, with some studies favoring the interfollicular epidermis
(Wong and Reiter, 2011; Youssef et al., 2010), the hair follicle
bulge region (Wang et al., 2011), or both locations (Grachtchouk
et al., 2011). Direct comparison of these results is complicated1162 Cell Reports 16, 1153–1165, July 26, 2016by the differences in the mouse models used to induce BCCs
by targeting oncogene expression or tumor suppressor loss to
specific subpopulations of cells in the skin.We set out to address
a slightly different question, which is why expression of activated
Smo using a Krt14 promoter that is universally active in interfol-
licular basal cells of both dorsal and tail skin gives rise to BCCs
mainly in the tail skin (Wong and Reiter, 2011; Youssef et al.,
2010). Our expression analysis identified a network of genes
linked to Smo expression in tail, but not dorsal, skin that included
components of theWnt/Lef1 and Shh signaling pathways. While
many questions remain to be addressed regarding the cellular
origins of skin BCCs and SCCs, we propose that mutant Smo
activated by K14-Cre may have a stronger effect in tail keratino-
cytes because of the specific wiring of the Smo gene expression
pattern in this tissue. Analyses of other Shh signaling compo-
nents may reveal tissue- or cell-type-specific patterns that could
explain the diverse phenotypes observed when carcinomas are
induced by different driver genes in subpopulations of skin target
cells (Peterson et al., 2015). Loss of Ptch1 can also lead to BCC
formation, but primarily in dorsal rather than tail skin (Wang et al.,
2011). The explanation of this phenotype is unknown, but it could
be due to differential wiring of the Ptch1 gene network in dorsal
and tail skin or to differences in levels of expression of alternative
genes, such as Ptch2, that can compensate for loss of Ptch1
(Adolphe et al., 2014). Indeed, while Ptch1 mRNA levels are
similar in dorsal and tail skins, Ptch2 is expressed at a signifi-
cantly higher level in the tails (data not shown), suggesting that
compensation may explain the relative lack of tail BCCs when
Ptch1 is deleted in this tissue.
Network Changes during Development of
Premalignancy
Mouse models of skin cancer initiated by the carcinogen
DMBA display a high specificity for activation of the Hras gene
by mutation at codon 61 (Bizub et al., 1986; Quintanilla et al.,
1986). This event can be circumvented in mice lacking expres-
sion of the Pten tumor suppressor gene in keratinocytes (Mao
et al., 2004), suggesting a connection between the Hras and
Pten signaling pathways. It was therefore of interest that an
unbiased screen for differentially correlated genes in normal
skin and Hras mutant papillomas from the same backcross
mouse population (Quigley et al., 2011) identified Pten as one
of the top rewired genes, in spite of minimal changes in mRNA
expression levels during tumor development. In premalignant
papillomas, Pten is correlated with a set of genes implicated
in alternative tumor suppressor pathways, including the
Trp53 (Rps26) and Tgfß (Smad4) pathways. However, these
correlations are disrupted in malignant carcinomas, suggesting
that this concerted suppressor network response to Hras
mutation has to be removed to permit tumor progression. The
mechanisms involved are not presently clear, but they do not
appear to include direct mutations in Pten as shown by exome
analysis of benign and malignant skin tumors (McCreery et al.,
2015).
These observations demonstrate how network analysis of
gene expression can reveal pathway engagement not obvious
from differential expression analysis (Figure 6). Methods such
as correlation analysis that identify relationships between
genes in the same compartment or across compartments in
intact tissues are a useful tool to understand the interactions
that underlie normal tissue homeostasis, responses to damage,
and development of progressive diseases, including neoplasia.
EXPERIMENTAL PROCEDURES
Animal Breeding and Tissue Collection
FVBBX mice were generated by breeding ([FVB/N 3 SPRET/Ei] 3 FVB/N).
Mice were housed in standard conditions, fed ad libitum, and sacrificed at
8 weeks of age. Animals were housed and treated in accordance with the reg-
ulations and protocols stipulated by the University of California, San Francisco
(UCSF) Institutional Animal Care and Use Committee (IACUC). For TPA treat-
ment, the dorsal skins of FVB/N, Spret/Ei, and FVB/N 3 Spret/Ei mice were
shaved and treated 2 days later with a single dose of TPA (200 ml of 104 M
solution in acetone) or vehicle alone. Mice were sacrificed at 0, 2, 4, 6, 24,
48, and 72 hr and after 1 week. Tissue was flash-frozen in liquid nitrogen
and stored at 80C.
Microarray Analysis
RNA was isolated using TRIzol (Invitrogen) according to the manufacturer’s
instructions. Residual genomic DNA was removed by DNase treatment
(Ambion). RNA quality was assessed using a Bioanalyzer (Agilent). Gene
expression was quantified using Affymetrix MoGene ST 1.1 arrays hybridized
on an Affymetrix GeneTitan instrument. Batch effects were reduced using
ComBat (Johnson et al., 2007). Affymetrix MoGene arrays were normalized
using the oligo package (Carvalho and Irizarry, 2010) and a probe database
prepared for FVBBX mice to avoid probes that intersect known FVB/N or
Spret/Ei SNPs (Quigley, 2015). Probesets expressed below background levels
(determined by expression of Y chromosome genes in female animals) or that
did notmap to RefSeq-annotated locations for genes were discarded. Multiple
probesets assigned to the same gene were collapsed to one signal using the
following rule: If two or more probesets had correlation >0.8, these were com-
bined by their mean and other probesets discarded. If no two probesets had
correlation >0.8, the probeset with the highest variance was used and other
probesets discarded. Normal/papilloma/carcinoma data were downloaded
from GEO (GEO: GSE21264). Raw FVBBX microarray data are available for
download at GEO as well (GEO: GSE52650).
Statistical Methods
Spearman rank correlation 5% genome-wide significance was established by
permutation (Churchill and Doerge, 1994). Statistical calculations were per-
formed in the R statistical environment (R Core Team, 2012) and CARMEN.
Differential expression was tested with SAM (Tusher et al., 2001). Differential
correlation was calculated in CARMEN using Fisher’s transformation of
Spearman rank correlation to determine the significance of a change in corre-
lation between two conditions. Multiple test correction was performed by
applying a Bonferroni correction to the number of gene pairs considered. Cor-
relation networks were displayed with Cytoscape 3.2 (Shannon et al., 2003).
Genotypes were measured with 240 custom-designed Applied Biosystems
TaqMan probes that distinguish the FVB/N and Spret/Ei genomes, measured
using the Wafergen platform (http://www.wafergen.com). Genotypes were
called using the manufacturer’s software. Erroneously called genotypes
were corrected and missing genotype data imputed using R/QTL package
(Broman et al., 2003). eQTL analysis was performed using CARMEN as
described previously (Quigley et al., 2009). CARMEN software and documen-
tation are available at http://davidquigley.com/carmen with source code avail-
able at https://github.com/DavidQuigley/QuantitativeGenetics. CARMEN is
written in C++ using the wxWidgets and Boost libraries (http://wxwidgets.
org; http://www.boost.org). For each gene, association with genotype was
tested within a chromosome by linear regression, with gene-wise significance
assessed by permutation testing and genome-wide significance tested using
permutation p values as input to the qvalue package (Storey and Tibshirani,
2003). eQTL LOD plots were generated with R/QTL (Broman et al., 2003). Dif-
ferential correlation significance was assessed by Bonferroni correction of the
Spearman correlation p value for the number of gene pairs considered.Tissue Staining
For Lrig1 and Krt79 staining, 5-mm skin sections were deparaffinized, and an-
tigen retrieval was performed in 10 mM sodium citrate solution (pH 6) or in Tril-
ogy pre-treatment solution (Cell Marque). Sections were blocked for 1 hr at
room temperature with 10% donkey serum (Abcam) diluted in PBS containing
0.3% Triton X-100 and incubated overnight with primary antibodies against
Lrig1 (goat, R&D) or Krt79 (rabbit, Abcam) at 4C. After washing in PBS, sec-
tions were incubated with blocking solution containing an Alexa Flour 555-
conjugated donkey anti-goat/rabbit secondary antibody (Molecular Probes)
and DAPI for 1 hr at room temperature. After another PBS wash, slides were
mounted using Citifluor. For other staining, tissues were fixed overnight in
4% paraformaldehyde (PFA) and embedded in paraffin. H&E stains were pre-
pared by the UCSF Gladstone core facility with a Leica ST 5020 multistainer.
For immunofluorescence, slides were depariffinized with citrisolve. Antigen
retrieval was performed with citrate. Slides were blocked in 10% goat serum
(50062Z, Invitrogen) with 0.3% Triton. The primary antibody was rabbit anti-
Smo (1:200, Abcam) overnight, followed by secondary antibody conjugated
with Alexa Fluor 555 (1:500, Invitrogen) and DAPI (Vectashield, Vector
Laboratories).
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